TFS CAPITAL LLC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 197 filers reported holding REPLIGEN CORP in Q3 2017. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
TFS CAPITAL LLC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q2 2017$581,000
-36.5%
14,012
-58.1%
0.23%
+35.7%
Q2 2016$915,000
-50.7%
33,446
-51.6%
0.17%
-37.1%
Q1 2016$1,855,000
+146.7%
69,168
+160.2%
0.27%
+229.6%
Q4 2015$752,000
-56.3%
26,586
-57.0%
0.08%
-51.2%
Q3 2015$1,721,000
+53.4%
61,802
+9.0%
0.17%
+55.1%
Q4 2014$1,122,000
-76.0%
56,678
-72.4%
0.11%
-70.9%
Q2 2014$4,680,000
+1439.5%
205,353
+822.0%
0.37%
+2528.6%
Q4 2013$304,000
-22.1%
22,273
-36.6%
0.01%
-22.2%
Q3 2013$390,000
+52.3%
35,129
+12.9%
0.02%
+63.6%
Q2 2013$256,00031,1150.01%
Other shareholders
REPLIGEN CORP shareholders Q3 2017
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders